SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-024065
Filing Date
2021-05-05
Accepted
2021-05-05 16:13:10
Documents
14
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rcus-8k_20210505.htm   iXBRL 8-K 33716
2 EX-99.1 rcus-ex991_6.htm EX-99.1 182635
3 GRAPHIC gae5rxbs0yyr000001.jpg GRAPHIC 17785
  Complete submission text file 0001564590-21-024065.txt   382711

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rcus-20210505.xsd EX-101.SCH 5776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20210505_lab.xml EX-101.LAB 18719
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20210505_pre.xml EX-101.PRE 11175
7 EXTRACTED XBRL INSTANCE DOCUMENT rcus-8k_20210505_htm.xml XML 3419
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 21893390
SIC: 2834 Pharmaceutical Preparations